Which gut bacteria increase colonic butyrate production?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Butyrate-Producing Gut Bacteria

The primary butyrate-producing bacteria in the human colon are Faecalibacterium prausnitzii, Roseburia species, Eubacterium rectale, Anaerostipes, Coprococcus, and Subdoligranulum, all belonging to the Firmicutes phylum, specifically clostridial clusters IV and XIVa 1, 2.

Key Butyrate-Producing Bacterial Groups

The most abundant and clinically relevant butyrate producers include:

  • Faecalibacterium prausnitzii (clostridial cluster IV) - One of the two most abundant butyrate-producing groups in the human colon 2
  • Eubacterium rectale/Roseburia species (clostridial cluster XIVa) - The other major abundant group 2
  • Roseburia faecis - Specifically enhanced by fructo-oligosaccharides 3
  • Coprococcus comes - Another butyrate producer stimulated by certain dietary fibers 3
  • Anaerostipes and Subdoligranulum - Additional members of the butyrate-producing community 1, 4

Dietary Strategies to Increase These Bacteria

Plant-Based Foods and Nuts

Nut consumption (particularly walnuts and almonds) significantly increases Roseburia, Clostridium, and Dialister populations, which directly produce butyrate from indigestible glycans like β-mannans found in nuts 5. The omega-3 fatty acids in nuts further enhance Roseburia abundance 5.

Fiber-Rich Foods

Vegan and plant-based diets high in fiber stimulate butyrate production through increased populations of beneficial bacteria, particularly through fermentation of dietary fiber 6. The high fiber content creates a favorable gut environment supporting butyrate-producing bacterial growth 6.

Specific fiber types show differential effects:

  • Fructo-oligosaccharides (FOS) preferentially promote butyrate-producing bacteria (Eubacterium rectale, Roseburia faecis, Coprococcus comes) and yield higher butyrate levels via the butyrate kinase pathway 3
  • Inulin-type fructans (ITF) and arabinoxylan-oligosaccharides (AXOS) demonstrate both bifidogenic and butyrogenic effects through cross-feeding interactions between bifidobacteria and butyrate-producing bacteria 4
  • Brassica vegetables (fiber-rich fraction) double populations of Eubacterium rectale group and Faecalibacterium prausnitzii after 2 weeks of consumption 7

Metabolic Pathways

These bacteria primarily metabolize carbohydrates through the butyryl-CoA: acetate CoA-transferase pathway, with most using this enzyme rather than butyrate kinase for the final step in butyrate synthesis 1, 2. A minority can also utilize amino acids via glutamate and lysine pathways to generate butyrate 1.

Clinical Significance

Populations of Faecalibacterium prausnitzii are decreased in Crohn's disease, while Roseburia relatives are particularly sensitive to dietary composition 2. The reduction in these butyrate-producing bacteria leads to decreased butyrate levels, which correlates with increased intestinal permeability, systemic inflammation, and neuroinflammation 8.

Common Pitfall

Do not assume all fiber sources equally promote butyrate production. FOS and similar prebiotics are superior to other soluble fibers like citrus pectin for specifically enhancing butyrate-producing bacteria 3. The chemical composition of dietary fiber determines which bacterial populations are stimulated and which short-chain fatty acids predominate.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.